Researchers validated a Japanese version of the ATTARI-12 scale to measure medical trainees' attitudes toward AI in healthcare.
Key Details
- 1The J-ATTARI-12 scale was developed and validated based on a nationwide survey of 326 Japanese medical students and residents.
- 2The scale assesses two dimensions: 'AI anxiety and aversion' and 'AI optimism and acceptance.'
- 3Psychometric evaluation showed good validity, reliability, and model fit.
- 4The tool enables structured assessment of readiness, concerns, and acceptance of AI in medical training.
- 5J-ATTARI-12 will be used in a new 'Medicine and AI' program at Juntendo University from 2026.
- 6Published in JMIR Medical Education on January 14, 2026.
Why It Matters
Understanding medical trainees’ attitudes toward AI is critical for effective curriculum development and the responsible integration of AI into clinical practice. The J-ATTARI-12 scale provides a culturally adapted tool to identify barriers and support the future workforce in adopting AI, including in radiology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.